Confirm delete?

Bertin Bioreagent
logo
All categories
Contact Us
You are here :

IP Receptor (human) Polyclonal Antibody

  • Photo non disponible
Cat No: 10005518
Antibodies - Polyclonal Antibodies
Cayman
€342.00
Price is excluding VAT and does not include packaging neither shipping

Prostaglandin I2 (PGI2) is a potent vasorelaxant and inhibitor of human platelet aggregation.{4375} The PGI2 receptor (IP receptor) also participates in signal transduction of the pain response, cardioprotection, and inflammation.{9050,5018,9805,8508,...

More
: 1 ea

This product can only be bought through Cayman Chemical. Please contact us.

- +
Territorial Availability: Available through Bertin Technologies only in Europe
Correlated keywords:
  • PGI-2 PGI western blot WB
Product Overview:
Prostaglandin I2 (PGI2) is a potent vasorelaxant and inhibitor of human platelet aggregation.{4375} The PGI2 receptor (IP receptor) also participates in signal transduction of the pain response, cardioprotection, and inflammation.{9050,5018,9805,8508,5466} Cloning of the murine and human IP receptors revealed a significant amino-terminal truncation of the human IP receptor compared to the murine receptor.{3173,1614} Cayman Chemical’s IP receptor antibody detects a 67 kDa band on immunoblot. The predicted migration of the deglycosylated protein is 40 kDa and bands at either 67 or 40 kDa may be detected depending on the degree of post-translational modification of the sample.{11563}
Size 1 ea
Shipping dry ice
Stability Store at -20 degrees; shelf life 365 days
Host Rabbit
Antigen Synthetic peptide from the N-terminal region of human IP receptor
Application(s)

WB

Formulation 500 µl of peptide affinity-purified antibody
Custom Code 3822.00
UNSPSC code 12352203

Cayman Chemical's mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare researchers is to offer the highest quality products with an affordable pricing policy.

Our scientists are experts in the synthesis, purification, and characterization of biochemicals ranging from small drug-like heterocycles to complex biolipids, fatty acids, and many others. We are also highly skilled in all aspects of assay and antibody development, protein expression, crystallization, and structure determination.

Over the past thirty years, Cayman developed a deep knowledge base in lipid biochemistry, including research involving the arachidonic acid cascade, inositol phosphates, and cannabinoids. This knowledge enabled the production of reagents of exceptional quality for cancer, oxidative injury, epigenetics, neuroscience, inflammation, metabolism, and many additional lines of research.

Our organic and analytical chemists specialize in the rapid development of manufacturing processes and analytical methods to carry out clinical and commercial GMP-API production. Pre-clinical drug discovery efforts are currently underway in the areas of bone restoration and repair, muscular dystrophy, oncology, and inflammation. A separate group of Ph.D.-level scientists are dedicated to offering Hit-to-Lead Discovery and Profiling Services for epigenetic targets. Our knowledgeable chemists can be contracted to perform complete sample analysis for analytes measured by the majority of our assays. We also offer a wide range of analytical services using LC-MS/MS, HPLC, GC, and many other techniques.

Accreditations
ISO/IEC 17025:2005
ISO Guide 34:2009

Cayman is a leader in the field of emerging drugs of abuse, providing high-purity Schedule I-V Controlled Substances to federally-licensed laboratories and qualified academic research institutions for forensic analyses. We are certified by ACLASS Accreditation Services with dual accreditation to ISO/IEC 17025:2005 and ISO Guide 34:2009.

/ We also advise you

Cross selling for this product : IP Receptor (human) Polyclonal Antibody There are 10 products.

Search